Dr. Perl on Potential CAR T-Cell Therapies in Hematologic Malignancies – OncLive
|
Dr. Perl on Potential CAR T-Cell Therapies in Hematologic Malignancies
OncLive Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses potential chimeric antigen receptor (CAR) T-cells in hematologic malignancies. CAR T-cell therapy is being explored in acute myeloid leukemia (AML), but … |
